TTY Biopharm Co Ltd (4105) — Free Cash Flow Generation Index
TTY Biopharm Co Ltd (4105) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of NT$744.17 Million represents 1% of operating cash flow (NT$778.89 Million). Read debt load of TTY Biopharm Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TTY Biopharm Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for TTY Biopharm Co Ltd across 9 annual periods. Explore 4105 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for TTY Biopharm Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for TTY Biopharm Co Ltd. For the full company profile including market capitalisation, see TTY Biopharm Co Ltd (4105) market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | NT$1.61 Billion | NT$1.76 Billion | NT$150.83 Million | ▲ +1.5% |
| 2024 | 0.90x | NT$1.22 Billion | NT$1.35 Billion | NT$134.29 Million | ▼ -0.9% |
| 2023 | 0.91x | NT$985.73 Million | NT$1.09 Billion | NT$99.58 Million | ▲ +2.0% |
| 2022 | 0.89x | NT$1.10 Billion | NT$1.24 Billion | NT$135.50 Million | ▼ -5.4% |
| 2021 | 0.94x | NT$1.18 Billion | NT$1.26 Billion | NT$74.15 Million | ▲ +43.8% |
| 2020 | 0.65x | NT$344.49 Million | NT$526.35 Million | NT$181.86 Million | ▼ -30.5% |
| 2019 | 0.94x | NT$1.14 Billion | NT$1.21 Billion | NT$69.86 Million | ▲ +2.4% |
| 2018 | 0.92x | NT$987.49 Million | NT$1.07 Billion | NT$74.09 Million | ▲ +1.9% |
| 2017 | 0.90x | NT$899.03 Million | NT$996.52 Million | NT$96.79 Million | — |